(Q40780741)

23 September 2017

1 reference

title

What constitutes evidence for drug efficacy in osteoporosis? (English)

1 reference

23 September 2017

0 references

J A Kanis

1

1 reference

PubMed ID

8241604

23 September 2017

language of work or name

1 reference

1 September 1993

1 reference

23 September 2017

1 reference

23 September 2017

3

1 reference

23 September 2017

5

1 reference

23 September 2017

391-399

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199303050-00001

23 September 2017

0 references

cites work

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Epidemiology of vertebral fractures in women

1 reference

12 December 2020

Epidemiology of vertebral osteoporosis

1 reference

12 December 2020

Bone hypertrophy and trabecular generation in Paget's disease and in fluoride-treated osteoporosis

1 reference

12 December 2020

A comparison of single and multi-site BMC measurements for assessment of spine fracture probability.

1 reference

12 December 2020

Bone density screening for osteoporosis

1 reference

12 December 2020

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

12 December 2020

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

1 reference

12 December 2020

Bone-density measurement

1 reference

12 December 2020

Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study

1 reference

12 December 2020

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

1 reference

12 December 2020

Epidemiology of osteoporosis and osteoporotic fractures

1 reference

12 December 2020

Fracture rates as a function of forearm mineral density in normal postmenopausal women: retrospective and prospective data

1 reference

12 December 2020

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

12 December 2020

Baseline measurement of bone mass predicts fracture in white women

1 reference

12 December 2020

The assessment of vertebral deformity: a method for use in population studies and clinical trials

1 reference

12 December 2020

A new approach to defining normal vertebral dimensions

1 reference

12 December 2020

Predicting fractures in women by using forearm bone densitometry

1 reference

12 December 2020

Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study

1 reference

12 December 2020

Classification of vertebral fractures

1 reference

12 December 2020

Thiazide diuretic agents and the incidence of hip fracture

1 reference

12 December 2020

Calcitriol treatment is not effective in postmenopausal osteoporosis

1 reference

12 December 2020

Definition of a spine fracture threshold based upon prospective fracture risk

1 reference

12 December 2020

Consensus development conference: prophylaxis and treatment of osteoporosis

1 reference

12 December 2020

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with calcitriol or calcium

1 reference

12 December 2020

Osteoporosis and osteopenia

1 reference

12 December 2020

Calcium requirements for optimal skeletal health in women

1 reference

12 December 2020

Long-term fluoride therapy of postmenopausal osteoporosis

1 reference

12 December 2020

The microanatomy of trabecular bone loss in normal aging men and women

1 reference

12 December 2020

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

1 reference

12 December 2020

Dietary calcium and risk of hip fracture: 14-year prospective population study

1 reference

12 December 2020

The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency

1 reference

12 December 2020

Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis

1 reference

12 December 2020

Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study

1 reference

12 December 2020

Involutional osteoporosis

1 reference

12 December 2020

Treatment of osteoporotic fracture

1 reference

12 December 2020

Vertebral morphometry: normative data.

1 reference

12 December 2020

Guidelines for clinical trials in osteoporosis. A position paper of the European Foundation for Osteoporosis and Bone Disease

1 reference

12 December 2020

Menopausal estrogen therapy and hip fractures

1 reference

12 December 2020

A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis

1 reference

12 December 2020

Intermittent cyclical etidronate treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Epidemiology of osteoporosis

1 reference

12 December 2020

A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis

1 reference

12 December 2020

10.2165/00002512-199303050-00001

Identifiers

DOI

1 reference

PubMed ID

8241604

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

8241604